• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    HCA Healthcare Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    4/29/25 4:39:03 PM ET
    $HCA
    Hospital/Nursing Management
    Health Care
    Get the next $HCA alert in real time by email
    8-K
    --12-31 false 0000860730 0000860730 2025-04-24 2025-04-24
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    PURSUANT TO SECTION 13 OR 15(d)

    OF THE SECURITIES EXCHANGE ACT OF 1934

    Date of Report (Date of earliest event reported): April 29, 2025 (April 24, 2025)

     

     

    HCA HEALTHCARE, INC.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-11239   27-3865930

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    One Park Plaza, Nashville, Tennessee   37203
    (Address of principal executive offices)   (Zip Code)

    Registrant’s telephone number, including area code: (615) 344-9551

    Not Applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class

     

    Trading
    Symbol(s)

     

    Name of each exchange
    on which registered

    Common Stock, $.01 par value per share   HCA   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 5.02.

    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

    Board of Directors Compensation Program

    On April 24, 2025, the Board of Directors (the “Board”) of HCA Healthcare, Inc. (the “Company”) approved the 2025-2026 Board of Directors Compensation Program, effective immediately, pursuant to which each non-management director will receive quarterly payment of the following cash compensation, as applicable (prorated for partial years):

     

      •  

    $130,000 annual retainer for service as a Board member;

     

      •  

    $30,000 annual retainer for service as Chair of the Audit and Compliance Committee;

     

      •  

    $25,000 annual retainer for service as Chair of each of the Compensation Committee, Finance and Investments Committee, Nominating and Corporate Governance Committee or Patient Safety and Quality of Care Committee;

     

      •  

    $100,000 annual retainer for service as the Chairman of the Board; and

     

      •  

    $50,000 annual retainer for service as the independent presiding director.

    Directors may elect to receive their annual retainer for service as a Board member or for service as Chairman of the Board or independent presiding director in cash or in the form of restricted share unit awards.

    In addition to the director compensation described above, each non-management director will receive an annual board equity award with a value of $220,000, awarded upon joining the Board (prorated for months of service) and at each annual meeting of the stockholders thereafter. These equity grants consist of restricted share units ultimately payable in shares of the Company’s common stock and vest as to 100% of the award on the sooner of the date of the Company’s next annual stockholders’ meeting or the first anniversary of the grant date, subject to the director’s continued service on the Board. The restricted share units will also immediately vest upon the occurrence of a Change in Control (as defined in the applicable grant agreement). The directors may elect to defer receipt of shares under the restricted share units granted as part of the annual board equity award and any restricted share units received in lieu of cash retainers until the date they cease to be members of the Board. Directors will also be reimbursed for reasonable expenses incurred in connection with their service. Each non-management director is expected to directly or indirectly acquire a number of shares of the Company’s common stock with a value of five times the value of the annual cash retainer for a director’s service on the Board within five years from the date on which they are elected to the Board.

    First Amendment to 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates

    The Board previously approved, subject to stockholder approval, the First Amendment (the “First Amendment”) to the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates (as amended by the First Amendment, the “Amended 2020 Stock Incentive Plan”). At the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) held on April 24, 2025 (as noted in Item 5.07 below), the Company’s stockholders approved the Amended 2020 Stock Incentive Plan. The First Amendment increases the number of shares of the Company’s common stock that may be issued by 13,150,000 shares and extends the term of the Amended 2020 Stock Incentive Plan to April 24, 2035. A detailed summary of the material terms of the Amended 2020 Stock Incentive Plan is included as part of Proposal 4 in the Company’s Definitive Proxy Statement on Schedule 14A, which was filed with the Securities and Exchange Commission on March 14, 2025 (the “Proxy Statement”), and is incorporated herein by reference. That summary and the foregoing description of the Amended 2020 Stock Incentive Plan do not purport to be complete and are qualified in their entirety by reference to the full text of the First Amendment, a copy of which is attached to this report as Exhibit 10.1 and is incorporated herein by reference.

     


    Item 5.03.

    Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

    At the Annual Meeting, the Company’s stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”), providing for the exculpation of officers as permitted by the Delaware General Corporation Law. On April 24, 2025, the Company filed the Certificate of Amendment with the Delaware Secretary of State, to be effective April 25, 2025. A copy of the Certificate of Amendment, as filed with the Delaware Secretary of State, is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

     

    Item 5.07.

    Submission of Matters to a Vote of Security Holders.

    The Company held its Annual Meeting on April 24, 2025. At the Annual Meeting, a total of 228,105,841 shares of the Company’s common stock, out of a total of 246,203,301 shares of common stock outstanding and entitled to vote as of the record date for the Annual Meeting, were represented in person or by proxy. Voting results from the Annual Meeting were as follows:

    1. The following nine director nominees were elected to the Company’s Board of Directors for a one-year term, or until such director’s respective successor is duly elected and qualified or until such director’s earlier death, resignation or removal, as follows:

     

       

    For

     

    Against

     

    Abstentions

     

    Broker Non-Votes

    Thomas F. Frist III

      203,253,730   9,073,785   127,446   15,650,880

    Samuel N. Hazen

      209,663,649   2,663,393   127,919   15,650,880

    Robert J. Dennis

      204,461,734   7,739,297   253,930   15,650,880

    Nancy-Ann DeParle

      188,280,461   23,255,380   919,120   15,650,880

    William R. Frist

      208,651,741   3,675,503   127,717   15,650,880

    Hugh F. Johnston

      196,321,939   15,989,478   143,544   15,650,880

    Michael W. Michelson

      204,653,775   7,666,672   134,514   15,650,880

    Wayne J. Riley, M.D.

      201,776,430   10,473,407   205,124   15,650,880

    Andrea B. Smith

      208,263,391   4,056,532   135,038   15,650,880

    2. The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025 was ratified as follows:

     

    For

     

    Against

     

    Abstentions

     

    Broker Non-Votes

    207,353,356   20,631,138   121,347   0

    3. The adoption of a non-binding advisory resolution on the Company’s named executive officer compensation as described in the Company’s 2025 proxy statement was approved as follows:

     

    For

     

    Against

     

    Abstentions

     

    Broker Non-Votes

    198,712,163   13,569,145   173,653   15,650,880

    4. The First Amendment to the 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates was approved as follows:

     

    For

     

    Against

     

    Abstentions

     

    Broker Non-Votes

    205,907,358   6,380,537   167,066   15,650,880

    5. The amendment to the Company’s amended and restated certificate of incorporation to provide for the exculpation of officers as permitted by Delaware law was approved as follows:

     

    For

     

    Against

     

    Abstentions

     

    Broker Non-Votes

    190,215,349   22,063,435   176,177   15,650,880

    6. The stockholder proposal regarding lavish golden parachutes as described in the Proxy Statement was not approved as follows:

     

    For

     

    Against

     

    Abstentions

     

    Broker Non-Votes

    61,554,461   150,753,703   146,797   15,650,880


    7. The stockholder proposal regarding an amendment to the Patient Safety and Quality of Care Committee charter as described in the Proxy Statement was not approved as follows:

     

    For

     

    Against

     

    Abstentions

     

    Broker Non-Votes

    20,409,871   190,298,680   1,746,410   15,650,880

    8. The stockholder proposal regarding a report on acquisition strategy as described in the Proxy Statement was not approved as follows:

     

    For

     

    Against

     

    Abstentions

     

    Broker Non-Votes

    25,509,044   186,487,003   458,914   15,650,880

     

    Item 9.01

    Financial Statements and Exhibits.

    (d) Exhibits:

     

    Exhibit

    No.

       Description
     3.1    Certificate of Amendment to Amended and Restated Certificate of Incorporation of HCA Healthcare, Inc., as filed with the Secretary of State of Delaware on April 24, 2025 with an effective date of April 25, 2025.
    10.1    First Amendment to 2020 Stock Incentive Plan for Key Employees of HCA Healthcare, Inc. and its Affiliates.
    104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    HCA HEALTHCARE, INC.
    By:  

    /s/ John M. Franck II

      John M. Franck II
      Vice President - Legal and Corporate Secretary

    Date: April 29, 2025

    Get the next $HCA alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $HCA

    DatePrice TargetRatingAnalyst
    5/29/2025$385.00Underweight → Equal Weight
    Wells Fargo
    4/15/2025$336.00Outperform → Neutral
    Robert W. Baird
    12/17/2024$380.00Neutral
    Analyst
    11/25/2024$400.00 → $320.00Equal Weight → Underweight
    Wells Fargo
    11/22/2024Outperform → Mkt Perform
    Raymond James
    10/11/2024$475.00Overweight
    KeyBanc Capital Markets
    9/3/2024$427.00Equal-Weight
    Morgan Stanley
    5/30/2024$396.00Outperform
    Robert W. Baird
    More analyst ratings

    $HCA
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • HCA Healthcare, Inc. 2nd Quarter 2025 Earnings Conference Call

      HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2025 Earnings Call When: Friday, July 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet:   https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/

      6/30/25 4:00:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Announces HCA Healthcare Foundation's $1 Million Grant to Enhance Work With Educate Texas

      HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation, through its Healthier Tomorrow Fund, will enhance its work with Educate Texas, an initiative of Communities Foundation of Texas, through a new $1 million grant. This donation builds upon the collaboration resulting from the Foundation's $1.35 million grant to the organization in 2022 and will continue to focus on increasing student access to programs that enable healthcare careers, including high schools in Texas that offer Pathways in Technology Early College High School (P-TECH) healthcare career tracks. Through this first grant, Educate Texas supported

      6/26/25 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Commits $5 Million to Belmont University's Thomas F. Frist, Jr. College of Medicine

      HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced a $5 million gift to the Thomas F. Frist, Jr. College of Medicine at Belmont University to support the Belmont Collaborative for Health Systems Innovation. Half of the gift will create the HCA Healthcare Health Systems Science Endowed Chair, and the other $2.5 million will be used for programmatic support in the Health Systems Science department. HCA Healthcare's endowed chair will be matched by the Johnson Academic Challenge, a matching fund program that will create up to 20 endowed professorships across Belmont's academic programs. This press release features multimedia. View the full releas

      5/21/25 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Bank Of America Corp /De/ bought $88,208 worth of shares (3,436 units at $25.67) and sold $79,816 worth of shares (3,178 units at $25.12) (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      3/28/25 4:11:57 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    SEC Filings

    See more
    • SEC Form S-8 filed by HCA Healthcare Inc.

      S-8 - HCA Healthcare, Inc. (0000860730) (Filer)

      6/23/25 4:49:07 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Inc. filed SEC Form 8-K: Other Events, Creation of a Direct Financial Obligation

      8-K - HCA Healthcare, Inc. (0000860730) (Filer)

      6/10/25 4:10:30 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • SEC Form 10-Q filed by HCA Healthcare Inc.

      10-Q - HCA Healthcare, Inc. (0000860730) (Filer)

      5/1/25 4:30:20 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • HCA upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded HCA from Underweight to Equal Weight and set a new price target of $385.00

      5/29/25 8:13:33 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA downgraded by Robert W. Baird with a new price target

      Robert W. Baird downgraded HCA from Outperform to Neutral and set a new price target of $336.00

      4/15/25 9:26:09 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • Analyst resumed coverage on HCA with a new price target

      Analyst resumed coverage of HCA with a rating of Neutral and set a new price target of $380.00

      12/17/24 8:04:06 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Leadership Updates

    Live Leadership Updates

    See more
    • HCA Healthcare Announces HCA Healthcare Foundation's Support of Girl Scouts Mental Wellness Patch Programs

      HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com

      9/19/23 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Appoints Jyric Sims President of Company's West Florida Division

      HCA Healthcare, Inc. (NYSE:HCA) today announced Jyric Sims, Ph.D., will become president of the company's West Florida Division, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420005364/en/Jyric Sims, Ph.D. (Photo: Business Wire) Sims, who currently is CEO of HCA Healthcare's Medical City Plano and Medical City Frisco hospitals, will succeed Ravi Chari, M.D., who recently announced he will retire after 15 years with the company to pursue opportunities in early-stage healthcare companies. A more than 20-year healthcare veteran, Sims has been with HCA Healthcare since 2011. He has served as chief executive

      4/20/23 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall

      HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Chuck Hall, HCA Healthcare's National Group president, will retire at the end of the year after nearly 36 years with the organization. Currently, Hall is responsible for HCA Healthcare's operations at 96 hospitals across 13 states. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005233/en/HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall (Photo: Business Wire) Over more than three decades, Hall has been influential in many successful initiatives that will benefit the company for years to come, inc

      8/17/22 8:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • CEO Hazen Samuel N gifted 90,076 shares and received a gift of 90,076 shares (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/15/25 5:56:49 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • EVP and COO Foster Jon M received a gift of 3,155 shares, disposed of $5,847,580 worth of shares (15,925 units at $367.19), acquired $5,847,580 worth of shares (15,925 units at $367.19), sold $5,797,661 worth of shares (15,698 units at $369.32) and gifted 3,155 shares, decreasing direct ownership by 59% to 11,566 units (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/15/25 5:54:39 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • EVP and CFO Marks Mike A gifted 935 shares, received a gift of 647 shares, disposed of $203,529 worth of shares (573 units at $355.20) and acquired $203,529 worth of shares (573 units at $355.20), closing all direct ownership in the company (SEC Form 4)

      4 - HCA Healthcare, Inc. (0000860730) (Issuer)

      5/8/25 6:40:51 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Financials

    Live finance-specific insights

    See more
    • HCA Healthcare, Inc. 2nd Quarter 2025 Earnings Conference Call

      HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q 2025 Earnings Call When: Friday, July 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet:   https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/

      6/30/25 4:00:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare Reports First Quarter 2025 Results

      HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same facility admissions increased 2.6 percent and same facility equivalent admissions increased 2.8 percent "The solid fundamentals we saw in our business the past several quarters continued into the first quarter of 2025," said

      4/25/25 7:30:00 AM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • HCA Healthcare, Inc. 1st Quarter 2025 Earnings Conference Call

      HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q 2025 Earnings Call When: Friday, April 25, 2025 at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20250404757460/en/ INVESTOR CONTACT: Frank Morgan

      4/4/25 4:00:00 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care

    $HCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/14/24 5:10:03 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/14/24 5:06:57 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by HCA Healthcare Inc. (Amendment)

      SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)

      2/13/24 5:06:27 PM ET
      $HCA
      Hospital/Nursing Management
      Health Care